EVMN Kyle Carver sold Evommune, Inc. shares — SEC Form 4SELLEvommune, Inc.

Kyle Carver, Chief Financial Officer at Evommune, Inc. (EVMN), sold 18,175 shares at $22.84 ($415K) on 2026-05-28, disclosed to the SEC on 2026-06-01.

SEC EDGAR Filing

0001757072-26-000005

View on SEC EDGAR

Trade context

Scheduled sale ($415k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.

Modest58/100

Nothing distinguishes this filing.

Opportunistic SellExercise & Sell

Filing Info

Filed2026-06-01

Traded2026-05-28

Accession0001757072-26-000005

SourceSEC EDGAR (Live)

Insider

NameKyle Carver

TitleChief Financial Officer

PIT GradeInsiderUnrated

View Company View Insider

Related Trades by This Insider

Ticker	Type	Filed	Value	7d Stock	Filing
EVMN	BUY	2026-07-10	$13K	—	Filing →

Get an email when an insider at EVMN files

Free account. Follow EVMN and up to 10 more companies.

Follow EVMN for free

EVMN Kyle Carver sold Evommune, Inc. shares — SEC Form 4SELLEvommune, Inc.

Filing Info

Insider

Related Trades by This Insider

Trade Details

Outcomes